These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4691763)

  • 1. [Calcium and inorganic phosphate fractions in serum in chronic renal failure].
    Raszeja-Wanic B; Gluszek J; Smarsz C
    Pol Arch Med Wewn; 1973 Feb; 50(2):143-50. PubMed ID: 4691763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of serum calcium and serum phosphate level in chronic kidney failure and their significance the diagnosis of hyperparathyroidism].
    Henning HV; Quellhorst E; Wolfram D; Jakob G; Scheler F
    Verh Dtsch Ges Inn Med; 1968; 74():442-5. PubMed ID: 5714362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin effect on total calcium, its fractions and phosphate concentration in healthy subjects and patients with chronic renal failure].
    Grajek S; Raszeja-Wanic B; Smarsz C
    Pol Tyg Lek; 1976 Nov; 31(46):1963-5. PubMed ID: 995734
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the control of phosphate in the progression of chronic renal failure.
    Barrientos A; Arteaga J; Rodicio JL; Alvarez Ude F; Alcazar JM; Ruilope LM
    Miner Electrolyte Metab; 1982 Mar; 7(3):127-33. PubMed ID: 7169978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium in patients on hemodialysis.
    Ring T; Halkier P; Hansen HH; Sanden AK; Nielsen C
    Clin Nephrol; 1995 May; 43(5):332-4. PubMed ID: 7634549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D; Tschöpe W; Böhles HJ; Mehls O
    Proc Eur Dial Transplant Assoc; 1981; 18():561-6. PubMed ID: 7329984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Human calcitonin and serum-phosphate.
    Silva OL; Becker KL; Selawry HP; Snider RH; Moore CF; Bivins LE; Shalhoub RJ
    Lancet; 1974 May; 1(7865):1055. PubMed ID: 4133736
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphate excretion in chronic renal failure: evidence for a mechanism other than circulating parathyroid hormone.
    Fotino S
    Clin Nephrol; 1977 Dec; 8(6):499-503. PubMed ID: 598054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium carbonate-induced effects on serum Ca X P product and serum creatinine in renal failure: a retrospective study.
    Walser M
    Adv Exp Med Biol; 1980; 128():281-7. PubMed ID: 7424678
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.
    Slatopolsky E; Weerts C; Lopez-Hilker S; Norwood K; Zink M; Windus D; Delmez J
    N Engl J Med; 1986 Jul; 315(3):157-61. PubMed ID: 3724805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 12. Removal of excess inorganic phosphate by haemoperfusion with composite beads.
    Sideman S; Manor D; Hoffer E; Tabak A; Lotan N; Mordochovich D; Brunner G
    Life Support Syst; 1983; 1(2):113-25. PubMed ID: 6679008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation.
    Moore J; Tomson CR; Tessa Savage M; Borrows R; Ferro CJ
    Clin Transplant; 2011; 25(3):406-16. PubMed ID: 20608946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical heterogeneity of calcitonin in renal failure.
    Lee JC; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1977 Sep; 45(3):528-33. PubMed ID: 903401
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function in chronic renal failure.
    Bloom AL; Evans EP; Branch RA
    Acta Univ Carol Med Monogr; 1972; 53():333-8. PubMed ID: 4670739
    [No Abstract]   [Full Text] [Related]  

  • 18. Silicon in chronic hemodialysis patients.
    Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O
    ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hyperphosphatemia in chronic renal failure].
    Babarykin DA; Afanas'eva GA; Shul'man OM; Luse LIa; Rozental' RL
    Ter Arkh; 1984; 56(7):64-6. PubMed ID: 6484838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.